BackRapport Therapeutics Overview

Rapport Therapeutics Operating Income

Operating Income for RAPP.

Quarterly Operating Income

$-24215000.00
10.67% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-122206000.00
31.31% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)